GSK plc — RNS

Regulatory news across GSK, GSK

Date	TIDM	Time	Date	TIDM	TitleTitle (filtered)	Company	Source
12/06/25	GSK	11:00:00	12 Jun 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK plc	PRN
25/05/22	GSK	15:41:00	25 May 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK plc	PRN
01/12/21	GSK	11:05:00	1 Dec 2021	Total Voting Rights	GSK	Total Voting Rights	GSK plc	PRN
24/07/19		13:02:36	24 Jul 2019	Price Monitoring Extension		Price Monitoring Extension	Glaxosmithkline PLC	RNS
24/07/19		13:00:03	24 Jul 2019	2nd Quarter Results		2nd Quarter Results	Glaxosmithkline PLC	RNS
24/07/19		11:00:06	24 Jul 2019	Non-Executive Chairman		Non-Executive Chairman	Glaxosmithkline PLC	RNS
22/07/19		18:00:01	22 Jul 2019	ViiV presents 96-week data from phase III study		ViiV presents 96-week data from phase III study	Glaxosmithkline PLC	RNS
15/07/19		19:19:44	15 Jul 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
15/07/19		19:18:58	15 Jul 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
15/07/19		19:16:12	15 Jul 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
15/07/19		12:42:29	15 Jul 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
15/07/19		08:00:06	15 Jul 2019	positive results in Phase 3 PRIMA study of ZEJULA		positive results in Phase 3 PRIMA study of ZEJULA	GlaxoSmithKline PLC	RNS
12/07/19		17:35:26	12 Jul 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
12/07/19		16:55:03	12 Jul 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
10/07/19		16:48:03	10 Jul 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
10/07/19		08:00:03	10 Jul 2019	ViiV switch study shows 2DR as effective as 3DR		ViiV switch study shows 2DR as effective as 3DR	GlaxoSmithKline PLC	RNS
03/07/19		10:00:02	3 Jul 2019	ViiV receives Dovato EU Marketing Authorisation		ViiV receives Dovato EU Marketing Authorisation	GlaxoSmithKline PLC	RNS
01/07/19		13:08:51	1 Jul 2019	Total Voting Rights		Total Voting Rights	GlaxoSmithKline PLC	RNS
12/06/19		18:10:04	12 Jun 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
07/06/19		08:00:02	7 Jun 2019	FDA approval for Nucala self-administration		FDA approval for Nucala self-administration	GlaxoSmithKline PLC	RNS
04/06/19		09:00:01	4 Jun 2019	CHMP positive on GSK's Nucala self-administration		CHMP positive on GSK's Nucala self-administration	GlaxoSmithKline PLC	RNS
03/06/19		15:31:20	3 Jun 2019	Total Voting Rights		Total Voting Rights	GlaxoSmithKline PLC	RNS
24/05/19		11:54:25	24 May 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
20/05/19		14:44:29	20 May 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
13/05/19		18:44:12	13 May 2019	Block listing Interim Review		Block listing Interim Review	GlaxoSmithKline PLC	RNS
13/05/19		17:19:34	13 May 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
08/05/19		19:23:10	8 May 2019	Result of AGM & GM		Result of AGM & GM	GlaxoSmithKline PLC	RNS
02/05/19		18:07:37	2 May 2019	Trelegy Ellipta asthma study met primary endpoint		Trelegy Ellipta asthma study met primary endpoint	GlaxoSmithKline PLC	RNS
01/05/19		16:11:48	1 May 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
01/05/19		15:32:41	1 May 2019	Total Voting Rights		Total Voting Rights	GlaxoSmithKline PLC	RNS
01/05/19		13:00:01	1 May 2019	1st Quarter Results		1st Quarter Results	GlaxoSmithKline PLC	RNS
29/04/19		13:00:05	29 Apr 2019	ViiV submits NDA for HIV monthly 2 drug injectable		ViiV submits NDA for HIV monthly 2 drug injectable	GlaxoSmithKline PLC	RNS
26/04/19		17:16:23	26 Apr 2019	ViiV receives CHMP Positive Opinion for Dovato		ViiV receives CHMP Positive Opinion for Dovato	GlaxoSmithKline PLC	RNS
16/04/19		18:36:41	16 Apr 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
16/04/19		18:35:41	16 Apr 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
16/04/19		18:23:02	16 Apr 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
16/04/19		18:14:22	16 Apr 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
15/04/19		15:45:40	15 Apr 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
12/04/19		17:47:07	12 Apr 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
12/04/19		17:33:42	12 Apr 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
11/04/19		18:01:17	11 Apr 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
09/04/19		08:00:02	9 Apr 2019	FDA approves ViiV's two-drug HIV regimen, Dovato		FDA approves ViiV's two-drug HIV regimen, Dovato	GlaxoSmithKline PLC	RNS
02/04/19		14:00:03	2 Apr 2019	Publication of AGM and GM Shareholder Documents		Publication of AGM and GM Shareholder Documents	GlaxoSmithKline PLC	RNS
01/04/19		17:36:53	1 Apr 2019	Total Voting Rights		Total Voting Rights	GlaxoSmithKline PLC	RNS
28/03/19		16:15:02	28 Mar 2019	GSK reporting changes - product sales and IFRS 16		GSK reporting changes - product sales and IFRS 16	GlaxoSmithKline PLC	RNS
25/03/19		17:02:13	25 Mar 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
21/03/19		16:00:01	21 Mar 2019	GSK announces further positive data from DREAMM-1		GSK announces further positive data from DREAMM-1	GlaxoSmithKline PLC	RNS
19/03/19		17:45:02	19 Mar 2019	Data from GARNET study evaluating dostarlimab		Data from GARNET study evaluating dostarlimab	GlaxoSmithKline PLC	RNS
18/03/19		07:00:03	18 Mar 2019	GSK Annual Report 2018 on Form 20-F		GSK Annual Report 2018 on Form 20-F	GlaxoSmithKline PLC	RNS
12/03/19		15:19:06	12 Mar 2019	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS

Showing 1351–1400 of 2,805 announcements